Friday, July 10, 2026

pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON

Disc Medicine

Disc Medicine is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker IRON. Primary therapeutic focus areas include Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falcip

321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON · NYSE Ticker
Company details
Status
Public
HQ
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
Employees
165
Programs
308
Drugs
443
Patents
706
Clinical program

Safety and efficacy of IMM-101 combined with...

Phase 2 · other · Limited metastatic pancreatic cancer

Safety and efficacy of IMM-101 combined with... for Limited metastatic pancreatic cancer is a Phase 2 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Disc Medicine
Phase
Phase 2
Modality
other
Indication
Limited metastatic pancreatic cancer
Status
active
Trials
1